New generation sequencing in pathogen discovery and microbial surveillance
Authors:
- Arianna CalistriACArianna Calistri
- Cristiano SalataCSCristiano Salata
- Cristina ParolinCPCristina Parolin
- Giorgio PalùGPGiorgio Palù
- 1 September 2013
- journal article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 11 (9) , 877-879
Abstract
The annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is recognized as the largest European congress for the presentation and discussion of the key priorities and more recent scientific developments in the fields of clinical microbiology and infection. This year, it attracted almost 10,000 participants from all over the world. Keynote lectures, symposia, meet-the-expert sessions, educational workshops, poster and oral sessions covered the diagnosis, treatment, epidemiology and prevention of infectious diseases, as well as related basic microbiology. Moreover, interactive sessions addressing specific subjects underlined the important educational aspect of the ECCMID's congress. The scientific program, abstracts, oral presentations are available at their website [101] . This meeting report is focused on one of the several challenging and one of the most transversal topics of the meeting: the application of the next-generation sequencing (NGS) to the microbial world.Keywords
This publication has 9 references indexed in Scilit:
- Updating benchtop sequencing performance comparisonNature Biotechnology, 2013
- The changing face of pathogen discovery and surveillanceNature Reviews Microbiology, 2013
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in HumansmBio, 2012
- Application of next-generation sequencing technologies in virologyJournal of General Virology, 2012
- Transforming clinical microbiology with bacterial genome sequencingNature Reviews Genetics, 2012
- Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Genetic Detection and Characterization of Lujo Virus, a New Hemorrhagic Fever–Associated Arenavirus from Southern AfricaPLOS Pathogens, 2009
- Ultra‐Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse‐Transcriptase Inhibitor (NRTI)–Treated Patients and NRTI‐Naive PatientsThe Journal of Infectious Diseases, 2009
- Metagenomic Approaches for Defining the Pathogenesis of Inflammatory Bowel DiseasesCell Host & Microbe, 2008